Glycobond
Glycobond is a medtech-company founded as a spin-off from research performed at Linköping University.
Glycobond operates in biotechnology, health care, medical based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA), founded in 2011.
Glycobond is positioned in biotechnology, health care, medical, a segment that rewards a clear, focused offering.
The company is recorded as being based in European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA).
It is recorded at the Grant stage.
Recorded headcount: c_00001_00010 employees.
Public records show total funding of about $5K.
| Sector | Biotechnology, Health Care, Medical |
|---|---|
| Headquarters | European Union (EU), Nordic Countries, Scandinavia, Europe, Middle East, and Africa (EMEA) |
| Founded | 2011 |
| Employees | c_00001_00010 |
| Stage | grant |
| Total funding | $50,000 |
Website: glycobond.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account